Respiratory pathogen panels

 

Methodology

Nucleic Acid Amplification (NAA)

 

Test Description

This test is designed to simultaneous qualitative detection and identification of nucleic acids of Respiratory pathogens in nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections.

 

COVID-19 With Influenza A/B and Respiratory Syncytial Virus, NAA (Test code-105)

SARS-Cov-2

Influenza A virus Panel (H1 and H3)

Influenza A virus H1-2009

Influenza A virus H3

Influenza B virus

Respiratory Syncytial Virus

 

Respiratory Pathogen Profile, PCR (Test code 106)

VIRAL PATHOGENS

Adenovirus 1 & 2

Cytomegalovirus(CMV/HHV5)

Epstein-Barr virus (EBV/HHV4)

Human Parechovirus

Human Respiratory syncytical virus A & B

Human Bocavirus

Human Rhinoviruses 1

Human Coronavirus 229E

Human Rhinoviruses 2

Human Coronavirus HKUI

Human Coronavirus NL63

Human Coronavirus OC43

Human Enteroviruses Panel (All human viruses, except EV_D68)

Human Enterovirus_D68

Human herpesvirus 6(HHV6)

Human metapneumovirus

Human Parainfluenza virus 1

Human Parainfluenza virus 2

Human Parainfluenza virus 3

Human Parainfluenza virus 4

Influenza A virus Panel (H1 and H3)

Influenza A virus H1-2009

Influenza A virus H3

Influenza B virus

Measles Virus

Middle East respiratory syndrome (MERS)

Mumps virus

Severe Acute Respiratory Syndrome Coronavirus (SARS)

Varicella zoster virus (VZV/HHV3)

 

BACTERIAL PATHOGENS

Bordetella Panel (B.pertussis+B.bronchiseptica+B.parapertussis)

Bordetella holmesii

Bordetella pertussis

Chlamydophila pneumoniae

Coxiella burnetii

Haemophilus influenzae

Klebsiella pneumoniae

Legionella pneumoniae

Moraxella catarrhalis

Mycoplasma pneumoniae

Staphylococcus aureus

Streptococcus pyogenes

Streptococcus pneumoniae

 

FUNGAL PATHOGEN

Pneumocystis Jirovecii

 

Specimen Requirements

Specimen type: Anterior nasal swab; nasopharyngeal Swab, mid-turbinate swab

Volume: One swab in viral transport, 0.3 mL minimum

Container: Viral Transport System

Storage Instructions: Per the package insert: Swabs in viral transport media are stable for 30 days at -15°C or below. Swabs in viral transport media are also stable for 4 hours at room temperature and 3 days refrigerated (2º to 8º C).

Causes for Rejection: Improper collection; inadequate specimen; improper labeling; specimen leaked in transit; quantity not sufficient for analysis; name discrepancies; specimen exceeding storage requirements; specimen types other than nasopharyngeal swab in viral transport media

 

Limitations

This test has been validated according to the FDA guidelines, by CLIA # 45D2209248. Our laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C section 263a, to perform high complexity tests. The assay is validated internally by COLA guidance. Test performance can be affected because the clinical spectrum of infection caused by SARS-CoV-2 is not fully known.

 

Expected Turnaround Time

1 day. Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider.

 

CPT: 87636, 87486; 87581; 87633; 87798